financetom
Business
financetom
/
Business
/
Biogen expects steady growth for Alzheimer's drug Leqembi in near term
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Biogen expects steady growth for Alzheimer's drug Leqembi in near term
Dec 3, 2024 7:16 AM

Dec 3 (Reuters) - Biogen expects growth of its keenly

watched Alzheimer's disease drug, Leqembi, to see a "linear

trend" in the United States in the near term, a company

executive said at a healthcare conference on Tuesday.

(Reporting by Mariam Sunny in Bengaluru; Editing by Shinjini

Ganguli)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved